Trial Profile
Effects of Pitavastatin on Insulin Sensitivity and Liver Fat
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 06 Nov 2021
Price :
$35
*
At a glance
- Drugs Pitavastatin (Primary)
- Indications Obesity
- Focus Therapeutic Use
- 20 Apr 2020 Results published in the Journal of Infectious Diseases
- 17 Sep 2018 Primary endpoint (Liver fat) has not been met, according to the results published in the Journal of Clinical Endocrinology and Metabolism
- 17 Sep 2018 Primary endpoint (Insulin-stimulated glucose uptake) has not been met, according to the results published in the Journal of Clinical Endocrinology and Metabolism